1 SPECT Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of SPECT Radiopharmaceuticals
1.2 SPECT Radiopharmaceuticals Segment by Type
1.2.1 Global SPECT Radiopharmaceuticals Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Technetium-99
1.2.3 Thallium-201
1.2.4 Gallium-67
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Other
1.3 SPECT Radiopharmaceuticals Segment by Application
1.3.1 Global SPECT Radiopharmaceuticals Sales Comparison by Application: (2022-2028)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Thyroid
1.4 Global SPECT Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global SPECT Radiopharmaceuticals Revenue 2017-2028
1.4.2 Global SPECT Radiopharmaceuticals Sales 2017-2028
1.4.3 SPECT Radiopharmaceuticals Market Size by Region: 2017 Versus 2021 Versus 2028
2 SPECT Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
2.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
2.3 Global SPECT Radiopharmaceuticals Average Price by Manufacturers (2017-2022)
2.4 Manufacturers SPECT Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 SPECT Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 SPECT Radiopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest SPECT Radiopharmaceuticals Players Market Share by Revenue
2.5.3 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SPECT Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America SPECT Radiopharmaceuticals Sales by Country
3.3.2 North America SPECT Radiopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe SPECT Radiopharmaceuticals Sales by Country
3.4.2 Europe SPECT Radiopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America SPECT Radiopharmaceuticals Sales by Country
3.6.2 Latin America SPECT Radiopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global SPECT Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2017-2022)
4.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
4.3 Global SPECT Radiopharmaceuticals Price by Type (2017-2022)
5 Global SPECT Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2017-2022)
5.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
5.3 Global SPECT Radiopharmaceuticals Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GE Healthcare SPECT Radiopharmaceuticals Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Cardinal Health
6.2.1 Cardinal Health Corporation Information
6.2.2 Cardinal Health Description and Business Overview
6.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Cardinal Health SPECT Radiopharmaceuticals Product Portfolio
6.2.5 Cardinal Health Recent Developments/Updates
6.3 Lantheus Medical Imaging
6.3.1 Lantheus Medical Imaging Corporation Information
6.3.2 Lantheus Medical Imaging Description and Business Overview
6.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Portfolio
6.3.5 Lantheus Medical Imaging Recent Developments/Updates
6.4 Bracco Imaging
6.4.1 Bracco Imaging Corporation Information
6.4.2 Bracco Imaging Description and Business Overview
6.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bracco Imaging SPECT Radiopharmaceuticals Product Portfolio
6.4.5 Bracco Imaging Recent Developments/Updates
6.5 Eczacibasi-Monrol Nuclear Products
6.5.1 Eczacibasi-Monrol Nuclear Products Corporation Information
6.5.2 Eczacibasi-Monrol Nuclear Products Description and Business Overview
6.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product Portfolio
6.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
6.6 IBA Molecular Imaging
6.6.1 IBA Molecular Imaging Corporation Information
6.6.2 IBA Molecular Imaging Description and Business Overview
6.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Portfolio
6.6.5 IBA Molecular Imaging Recent Developments/Updates
6.7 Jubilant Life Sciences
6.6.1 Jubilant Life Sciences Corporation Information
6.6.2 Jubilant Life Sciences Description and Business Overview
6.6.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Product Portfolio
6.7.5 Jubilant Life Sciences Recent Developments/Updates
7 SPECT Radiopharmaceuticals Manufacturing Cost Analysis
7.1 SPECT Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of SPECT Radiopharmaceuticals
7.4 SPECT Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 SPECT Radiopharmaceuticals Distributors List
8.3 SPECT Radiopharmaceuticals Customers
9 SPECT Radiopharmaceuticals Market Dynamics
9.1 SPECT Radiopharmaceuticals Industry Trends
9.2 SPECT Radiopharmaceuticals Market Drivers
9.3 SPECT Radiopharmaceuticals Market Challenges
9.4 SPECT Radiopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 SPECT Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Type (2023-2028)
10.1.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Type (2023-2028)
10.2 SPECT Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Application (2023-2028)
10.2.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Application (2023-2028)
10.3 SPECT Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Region (2023-2028)
10.3.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
